» Articles » PMID: 14973191

Human MicroRNA Genes Are Frequently Located at Fragile Sites and Genomic Regions Involved in Cancers

Overview
Specialty Science
Date 2004 Feb 20
PMID 14973191
Citations 1777
Authors
Affiliations
Soon will be listed here.
Abstract

A large number of tiny noncoding RNAs have been cloned and named microRNAs (miRs). Recently, we have reported that miR-15a and miR-16a, located at 13q14, are frequently deleted and/or down-regulated in patients with B cell chronic lymphocytic leukemia, a disorder characterized by increased survival. To further investigate the possible involvement of miRs in human cancers on a genome-wide basis, we have mapped 186 miRs and compared their location to the location of previous reported nonrandom genetic alterations. Here, we show that miR genes are frequently located at fragile sites, as well as in minimal regions of loss of heterozygosity, minimal regions of amplification (minimal amplicons), or common breakpoint regions. Overall, 98 of 186 (52.5%) of miR genes are in cancer-associated genomic regions or in fragile sites. Moreover, by Northern blotting, we have shown that several miRs located in deleted regions have low levels of expression in cancer samples. These data provide a catalog of miR genes that may have roles in cancer and argue that the full complement of miRs in a genome may be extensively involved in cancers.

Citing Articles

Plasma miR-145-5p Levels and Risk of Future Cancer-Results from the HUNT Study.

Antoun C, Oto J, Morelli V, Hveem K, Braekkan S, Medina P Int J Mol Sci. 2025; 26(5).

PMID: 40076809 PMC: 11899732. DOI: 10.3390/ijms26052191.


Experimental Validation of miR-4443, miR-572, and miR-150-5p in Serum and Tissue of Breast Cancer Patients as a Potential Diagnostic Biomarker: A Study Based on Bioinformatics Prediction.

Mardi A, Ghovahi A, Abbasvandi F, Amani D Biochem Genet. 2025; .

PMID: 40064800 DOI: 10.1007/s10528-025-11057-8.


Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis.

Jiang Y, Qi S, Zhang R, Zhao R, Fu Y, Fang Y Front Oncol. 2025; 14:1483521.

PMID: 39935848 PMC: 11810725. DOI: 10.3389/fonc.2024.1483521.


MicroRNAs Expression Profile in MN1-Altered Astroblastoma.

Gianno F, Miele E, Sabato C, Ferretti E, Minasi S, Buttarelli F Biomedicines. 2025; 13(1).

PMID: 39857696 PMC: 11762140. DOI: 10.3390/biomedicines13010112.


MicroRNA as a Potential Diagnostic and Prognostic Biomarker in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.

Khanmohammadi S, Masrour M, Fallahtafti P, Hasani F Cancer Rep (Hoboken). 2025; 8(1):e70070.

PMID: 39854617 PMC: 11760998. DOI: 10.1002/cnr2.70070.


References
1.
Cillo C, Faiella A, Cantile M, Boncinelli E . Homeobox genes and cancer. Exp Cell Res. 1999; 248(1):1-9. DOI: 10.1006/excr.1999.4451. View

2.
di Iasio M, Calin G, Tibiletti M, Vorechovsky I, Benediktsson K, Taramelli R . Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. Oncogene. 1999; 18(8):1635-8. DOI: 10.1038/sj.onc.1202453. View

3.
Tsuchiya E, Tanigami A, Ishikawa Y, Nishida K, Hayashi M, Tokuchi Y . Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer. Jpn J Cancer Res. 2000; 91(6):589-96. PMC: 5926396. DOI: 10.1111/j.1349-7006.2000.tb00986.x. View

4.
Pollard S, Holland P . Evidence for 14 homeobox gene clusters in human genome ancestry. Curr Biol. 2000; 10(17):1059-62. DOI: 10.1016/s0960-9822(00)00676-x. View

5.
Pasquinelli A, Reinhart B, Slack F, Martindale M, Kuroda M, Maller B . Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000; 408(6808):86-9. DOI: 10.1038/35040556. View